why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: June 20, 2025

Clinical Trial: To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg Orally Dispersible Tablet in Healthy, Adult, Human Subjects Under Fasting Conditions

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Allergic Rhino-Conjunctivitis

Study Type: INTERVENTIONAL


Official Title: An Open Label, Balanced, Randomized, Single Dose, Two Treatment, Two Sequence, Four Period, Full Replicate, Crossover, Oral Bioequivalence Study in Healthy, Adult, Human Subjects Under Fasting Conditi

Brief Summary: An open label, balanced, randomized single-dose, two-treatment, two sequence, four-period, Full Replicate, crossover oral bioequivalence study in healthy, adult, human subjects under fasting condition.

Read more